Torthaí cuardaigh - Pierre‐Paul Bringuier

  • 1 - 7 toradh as 7 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Melanoma Patients under Vemurafenib: Prospective Follow-Up of Melanocytic Lesions by Digital Dermoscopy

    Melanoma Patients under Vemurafenib: Prospective Follow-Up of Melanocytic Lesions by Digital Dermoscopy de réir Marie Perier‐Muzet, L. Thomas, Nicolas Poulalhon, S. Debarbieux, Pierre‐Paul Bringuier, Gérard Duru, L. Depaepe, B. Balme, Stéphane Dalle

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    <i>BRAF</i>Mutation Status in Gastrointestinal Stromal Tumors

    <i>BRAF</i>Mutation Status in Gastrointestinal Stromal Tumors de réir Isabelle Hostein, Nicolas Faur, Charlotte Primois, Frédérique Boury, Jérome Denard, Jean‐François Emile, Pierre‐Paul Bringuier, Jean–Yves Scoazec, Jean‐Michel Coindre

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Digenic Inheritance of Monoallelic <i>MUTYH</i> and <i>POLE</i> Germline Variants in Adrenocortical Carcinoma: Implications for Tumorigenesis and Immunotherapy

    Digenic Inheritance of Monoallelic <i>MUTYH</i> and <i>POLE</i> Germline Variants in Adrenocortical Carcinoma: Implications for Tumorigenesis and Immunotherapy de réir Jonathan Lopez, Adrien Buisson, Adel Ounnas, Gaëlle Tachon, Alain Viari, Florence de Fraipont, Juliette Albuisson, Marc Barritault, Pierre‐Paul Bringuier, Jean‐Paul Feugeas, Anne Mc Leer, Ahmed Bouras

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    <i>KIT</i> and <i>PDGFRA</i> Mutations and the Risk of GI Stromal Tumor Recurrence

    <i>KIT</i> and <i>PDGFRA</i> Mutations and the Risk of GI Stromal Tumor Recurrence de réir Heikki Joensuu, Piotr Rutkowski, Toshirou Nishida, Sonja E. Steigen, Peter Brabec, Lukáš Plank, Bengt Nilsson, Chiara Braconi, Andrea Bordoni, Magnús K. Magnússon, Jozef Šufliarský, Massimo Federico, Jón G. Jónasson, Isabelle Hostein, Pierre-Paul Bringuier, Jean-François Emile

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing

    Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing de réir Françoise Ducimetière, A. Lurkin, Dominique Ranchère‐Vince, Anne‐Valérie Decouvelaere, Michel Péoc’h, Luc Istier, P. Chalabreysse, C Müller, Laurent Alberti, Pierre‐Paul Bringuier, Jean–Yves Scoazec, Anne‐Marie Schott, Christophe Bergeron, Dominic Cellier, Jean‐Yves Blay, Isabelle Ray‐Coquard

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)

    Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy) de réir Jessica Garcia, Julien Forestier, Eric Dusserre, Anne‐Sophie Wozny, Florence Geiguer, P. Merle, Claire Tissot, Carole Ferraro‐Peyret, Frederick S. Jones, Daniel L. Edelstein, Valérie Cheynet, Claire Bardel, Gaëlle Vilchez, Zhenyu Xu, Pierre Paul Bringuier, Marc Barritault, Karen Brengle-Pesce, Marielle Guillet, Marion Chauvenet, Brigitte Manship, Marie Brevet, Claire Rodriguez‐Lafrasse, Valérie Hervieu, S. Couraud, Thomas Walter, Léa Payen

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

    Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT) de réir Fabrice Barlési, Julien Mazières, Jean‐Philippe Merlio, D. Debieuvre, Jean Mosser, H. Léna, L’Houcine Ouafik, Benjamin Besse, Isabelle Rouquette, Virginie Westeel, Fabienne Escande, I. Monnet, Antoinette Lemoine, Rémi Veillon, Hélène Blons, Clarisse Audigier-Valette, Pierre‐Paul Bringuier, R. Lamy, Michèle Beau‐Faller, Jean-Louis Pujol, Jean‐Christophe Sabourin, Frédérique Penault‐Llorca, Marc G. Denis, Sylvie Lantuéjoul, Franck Morin, Quân Tran, Pascale Missy, Alexandra Langlais, B. Milleron, J. Cadranel, Jean‐Charles Soria, Gérard Zalcman

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: